Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoptrin, Soluble CD40-ligand and Ischemic Stroke: a Clinical Perspective

NCT02974192 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT02974192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02974192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoptrin, Soluble CD40-ligand and Ischemic Stroke: a Clinical Perspective
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2016
Completion date
March 31, 2017
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke